Literature DB >> 32886840

Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation.

Rolle Rahikainen1, Pramila Rijal2, Tiong Kit Tan2, Hung-Jen Wu1, Anne-Marie C Andersson1,3, Jordan R Barrett4, Thomas A Bowden5, Simon J Draper4, Alain R Townsend2, Mark Howarth1.   

Abstract

Matching of symmetry at interfaces is a fundamental obstacle in molecular assembly. Virus-like particles (VLPs) are important vaccine platforms against pathogenic threats, including Covid-19. However, symmetry mismatch can prohibit vaccine nanoassembly. We established an approach for coupling VLPs to diverse antigen symmetries. SpyCatcher003 enabled efficient VLP conjugation and extreme thermal resilience. Many people had pre-existing antibodies to SpyTag:SpyCatcher but less to the 003 variants. We coupled the computer-designed VLP not only to monomers (SARS-CoV-2) but also to cyclic dimers (Newcastle disease, Lyme disease), trimers (influenza hemagglutinins), and tetramers (influenza neuraminidases). Even an antigen with dihedral symmetry could be displayed. For the global challenge of influenza, SpyTag-mediated display of trimer and tetramer antigens strongly induced neutralizing antibodies. SpyCatcher003 conjugation enables nanodisplay of diverse symmetries towards generation of potent vaccines.
© 2020 The Authors. Published by Wiley-VCH GmbH.

Entities:  

Keywords:  SpyTag; bioconjugation; nanoparticle; nanotechnology; vaccines

Mesh:

Substances:

Year:  2020        PMID: 32886840      PMCID: PMC7821241          DOI: 10.1002/anie.202009663

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  40 in total

1.  Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity.

Authors:  Timothy J Powell; Jonathan D Silk; Jane Sharps; Ervin Fodor; Alain R M Townsend
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

2.  Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains.

Authors:  J A Tree; C Richardson; A R Fooks; J C Clegg; D Looby
Journal:  Vaccine       Date:  2001-05-14       Impact factor: 3.641

3.  Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.

Authors:  Fu-Shi Quan; Min-Chul Kim; Byeong-Jae Lee; Jae-Min Song; Richard W Compans; Sang-Moo Kang
Journal:  Virology       Date:  2012-06-02       Impact factor: 3.616

4.  Dual Plug-and-Display Synthetic Assembly Using Orthogonal Reactive Proteins for Twin Antigen Immunization.

Authors:  Karl D Brune; Can M Buldun; Yuanyuan Li; Iona J Taylor; Florian Brod; Sumi Biswas; Mark Howarth
Journal:  Bioconjug Chem       Date:  2017-05-05       Impact factor: 4.774

5.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

6.  Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.

Authors:  Huong Q McLean; Mark G Thompson; Maria E Sundaram; Burney A Kieke; Manjusha Gaglani; Kempapura Murthy; Pedro A Piedra; Richard K Zimmerman; Mary Patricia Nowalk; Jonathan M Raviotta; Michael L Jackson; Lisa Jackson; Suzanne E Ohmit; Joshua G Petrie; Arnold S Monto; Jennifer K Meece; Swathi N Thaker; Jessie R Clippard; Sarah M Spencer; Alicia M Fry; Edward A Belongia
Journal:  J Infect Dis       Date:  2014-11-18       Impact factor: 5.226

7.  Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.

Authors:  Karl D Brune; Darren B Leneghan; Iona J Brian; Andrew S Ishizuka; Martin F Bachmann; Simon J Draper; Sumi Biswas; Mark Howarth
Journal:  Sci Rep       Date:  2016-01-19       Impact factor: 4.379

8.  SnoopLigase peptide-peptide conjugation enables modular vaccine assembly.

Authors:  Anne-Marie C Andersson; Can M Buldun; David J Pattinson; Simon J Draper; Mark Howarth
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

9.  Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus.

Authors:  Jessica Marcandalli; Brooke Fiala; Sebastian Ols; Michela Perotti; Willem de van der Schueren; Joost Snijder; Edgar Hodge; Mark Benhaim; Rashmi Ravichandran; Lauren Carter; Will Sheffler; Livia Brunner; Maria Lawrenz; Patrice Dubois; Antonio Lanzavecchia; Federica Sallusto; Kelly K Lee; David Veesler; Colin E Correnti; Lance J Stewart; David Baker; Karin Loré; Laurent Perez; Neil P King
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

Review 10.  NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

Authors:  Florian Krammer; Ron A M Fouchier; Maryna C Eichelberger; Richard J Webby; Kathryn Shaw-Saliba; Hongquan Wan; Patrick C Wilson; Richard W Compans; Ioanna Skountzou; Arnold S Monto
Journal:  mBio       Date:  2018-04-03       Impact factor: 7.867

View more
  14 in total

Review 1.  Nanocarriers based on bacterial membrane materials for cancer vaccine delivery.

Authors:  Xiao Zhao; Ruifang Zhao; Guangjun Nie
Journal:  Nat Protoc       Date:  2022-07-25       Impact factor: 17.021

2.  SpySwitch enables pH- or heat-responsive capture and release for plug-and-display nanoassembly.

Authors:  Susan K Vester; Rolle Rahikainen; Irsyad N A Khairil Anuar; Rory A Hills; Tiong Kit Tan; Mark Howarth
Journal:  Nat Commun       Date:  2022-06-28       Impact factor: 17.694

3.  Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation.

Authors:  Rolle Rahikainen; Pramila Rijal; Tiong Kit Tan; Hung-Jen Wu; Anne-Marie C Andersson; Jordan R Barrett; Thomas A Bowden; Simon J Draper; Alain R Townsend; Mark Howarth
Journal:  Angew Chem Int Ed Engl       Date:  2020-10-27       Impact factor: 15.336

4.  A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.

Authors:  Tiong Kit Tan; Pramila Rijal; Rolle Rahikainen; Anthony H Keeble; Lisa Schimanski; Saira Hussain; Ruth Harvey; Jack W P Hayes; Jane C Edwards; Rebecca K McLean; Veronica Martini; Miriam Pedrera; Nazia Thakur; Carina Conceicao; Isabelle Dietrich; Holly Shelton; Anna Ludi; Ginette Wilsden; Clare Browning; Adrian K Zagrajek; Dagmara Bialy; Sushant Bhat; Phoebe Stevenson-Leggett; Philippa Hollinghurst; Matthew Tully; Katy Moffat; Chris Chiu; Ryan Waters; Ashley Gray; Mehreen Azhar; Valerie Mioulet; Joseph Newman; Amin S Asfor; Alison Burman; Sylvia Crossley; John A Hammond; Elma Tchilian; Bryan Charleston; Dalan Bailey; Tobias J Tuthill; Simon P Graham; Helen M E Duyvesteyn; Tomas Malinauskas; Jiandong Huo; Julia A Tree; Karen R Buttigieg; Raymond J Owens; Miles W Carroll; Rodney S Daniels; John W McCauley; David I Stuart; Kuan-Ying A Huang; Mark Howarth; Alain R Townsend
Journal:  Nat Commun       Date:  2021-01-22       Impact factor: 14.919

5.  Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.

Authors:  Alexander A Cohen; Priyanthi N P Gnanapragasam; Yu E Lee; Pauline R Hoffman; Susan Ou; Leesa M Kakutani; Jennifer R Keeffe; Hung-Jen Wu; Mark Howarth; Anthony P West; Christopher O Barnes; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Science       Date:  2021-01-12       Impact factor: 47.728

Review 6.  Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2.

Authors:  Chulwoo Kim; Jae-Deog Kim; Sang-Uk Seo
Journal:  J Microbiol       Date:  2022-01-28       Impact factor: 2.902

7.  Embedding a membrane protein into an enveloped artificial viral replica.

Authors:  Hiroto Furukawa; Hiroshi Inaba; Yoshihiro Sasaki; Kazunari Akiyoshi; Kazunori Matsuura
Journal:  RSC Chem Biol       Date:  2021-12-21

Review 8.  Virus-like particles against infectious disease and cancer: guidance for the nano-architect.

Authors:  Rory A Hills; Mark Howarth
Journal:  Curr Opin Biotechnol       Date:  2021-10-29       Impact factor: 9.740

9.  Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model.

Authors:  Andrea Aebischer; Kerstin Wernike; Patricia König; Kati Franzke; Paul J Wichgers Schreur; Jeroen Kortekaas; Marika Vitikainen; Marilyn Wiebe; Markku Saloheimo; Ronen Tchelet; Jean-Christophe Audonnet; Martin Beer
Journal:  Vaccines (Basel)       Date:  2021-06-15

10.  Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic.

Authors:  Wan Lu; Zhuangzhuang Zhao; Yao-Wei Huang; Bin Wang
Journal:  Int J Biol Macromol       Date:  2022-01-20       Impact factor: 6.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.